SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-191159
Filing Date
2020-07-10
Accepted
2020-07-10 17:05:02
Documents
13
Period of Report
2020-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d29647d8k.htm   iXBRL 8-K 27506
2 EX-10.1 d29647dex101.htm EX-10.1 105533
  Complete submission text file 0001193125-20-191159.txt   289070

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20200707.xsd EX-101.SCH 3082
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20200707_lab.xml EX-101.LAB 18908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20200707_pre.xml EX-101.PRE 11871
6 EXTRACTED XBRL INSTANCE DOCUMENT d29647d8k_htm.xml XML 3513
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 201023728
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences